EdenTree Asset Management’s AbbVie ABBV Stock Holding History

EdenTree Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$703K	Hold	2,800	–	–	0.21%	63
2026 Q1	$609K	Hold	2,800	–	–	0.18%	62
2025 Q4	$640K	Hold	2,800	–	–	0.2%	59
2025 Q3	$648K	Hold	2,800	–	–	0.16%	59
2025 Q2	$520K	Hold	2,800	–	–	0.14%	61
2025 Q1	$587K	Hold	2,800	–	–	0.2%	60
2024 Q4	$498K	Hold	2,800	–	–	0.14%	63
2024 Q3	$553K	Hold	2,800	–	–	0.16%	64
2024 Q2	$480K	Hold	2,800	–	–	0.15%	63
2024 Q1	$509K	Sell	2,800 -8,300	-75%	-$1.43M	0.16%	65
2023 Q4	$1.72M	Hold	11,100	–	–	0.53%	37
2023 Q3	$1.66M	Sell	11,100 -5,000	-31%	-$734K	0.65%	33
2023 Q2	$2.17M	Buy	+16,100	New	+$2.36M	0.74%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EdenTree Asset Management's ABBV Position: Q2 2026 in Review

EdenTree Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,800 shares worth $703K. The position accounts for 0.21% of the portfolio, ranked #63.

EdenTree Asset Management first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.17M in Q2 2023. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

EdenTree Asset Management held 2,800 shares of AbbVie worth $703K as of Q2 2026.
EdenTree Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.21% of EdenTree Asset Management's portfolio in Q2 2026, its #63 holding.
EdenTree Asset Management first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
EdenTree Asset Management's AbbVie position peaked at $2.17M in Q2 2023.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EdenTree Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.